Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions

Norgen, 2007, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, 45, S5, 10.1016/j.jvs.2006.12.037 Tendera, 2011, ESC Guidelines on the diagnosis and treatment of peripheral artery diseases, Eur Heart J, 32, 2851, 10.1093/eurheartj/ehr211 Krankenberg, 2007, Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length, Circulation, 116, 285, 10.1161/CIRCULATIONAHA.107.689141 Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Eng J Med, 354, 1879, 10.1056/NEJMoa051303 Schillinger, 2007, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115, 2745, 10.1161/CIRCULATIONAHA.107.688341 Bosiers, 2009, Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study, J Endovasc Ther, 16, 261, 10.1583/08-2676.1 Laird, 2010, Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial, Circ Cardiovasc Interv, 3, 267, 10.1161/CIRCINTERVENTIONS.109.903468 Tosaka, 2012, Classification and clinical impact of restenosis after femoropopliteal stenting, J Am Coll Cardiol, 59, 16, 10.1016/j.jacc.2011.09.036 Armstrong, 2013, Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention, Catheter Cardiovasc Interv, 10.1002/ccd.24983 Duda S, Scheinert D, Zeller T, Tepe G, Krankenberg H, Scholte KL, et al. Twelve-month results of a randomized multi-center head-to-head comparison of the S.M.A.R.T. CONTROL nitinol Stent (Cordis) with the Luminexx 6F Stent (Bard) for the treatment of long TASC C and D superficial femoral artery lesions: the SUPER-SL study. Abstract presented at CIRSE 2008; September 13-17, 2008; Copenhagen, Denmark. Ihnat, 2008, Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score, J Vasc Surg, 47, 967, 10.1016/j.jvs.2007.12.050 Gur, 2011, Clinical outcomes and implications of failed infrainguinal endovascular stents, J Vasc Surg, 53, 658, 10.1016/j.jvs.2010.09.069 Al-Nouri, 2012, Failed superficial femoral artery intervention for advanced infrainguinal occlusive disease has a significant negative impact on limb salvage, J Vasc Surg, 56, 106, 10.1016/j.jvs.2011.10.108 Pulli, 2012, Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease, J Vasc Surg, 55, 105, 10.1016/j.jvs.2011.07.050 Hunink, 1993, Risks and benefits of femoropopliteal percutaneous balloon angioplasty, J Vasc Surg, 17, 183, 10.1016/0741-5214(93)90022-E Conrad, 2006, Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series, J Vasc Surg, 44, 762, 10.1016/j.jvs.2006.06.025 Dearing, 2009, Primary stenting of the superficial femoral and popliteal artery, J Vasc Surg, 50, 542, 10.1016/j.jvs.2009.04.019 Schoenefeld, 2012, Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents, VASA, 41, 49, 10.1024/0301-1526/a000163 Matsumura, 2013, The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the Protégé Everflex nitinol stent system II (DURABILITY II), J Vasc Surg, 58, 73, 10.1016/j.jvs.2012.12.066 Scheinert, 2005, Prevalence and clinical impact of stent fracture after femoropopliteal stenting, J Am Coll Cadiol, 45, 312, 10.1016/j.jacc.2004.11.026 Robertson, 2012, Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment, Cochrane Database Syst Rev, 8, 10.1002/14651858.CD002071.pub3 Laird, 2012, Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis, Catheter Cardiovasc Interv, 80, 852, 10.1002/ccd.23475 Shammas, 2012, Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center, Cardiovasc Revasc Med, 13, 224, 10.1016/j.carrev.2012.03.004 Zeller, 2013, Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents, JACC: Cardiovasc Interv, 6, 274 Stabile, 2012, Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis, J Am Coll Cardiol, 60, 1739, 10.1016/j.jacc.2012.07.033